
Mirum Pharmaceuticals Inc (MIRM)
NASDAQ
年末 2023年12月31日 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 0 | 0 | 0 | 19.14M | 77.06M | 186.37M |
営業利益 | -17.41M | -54.74M | -104.3M | -173.41M | -131.22M | -109.15M |
税引前収入 | -17.35M | -52.53M | -103.26M | -83.95M | -142.07M | -162.42M |
純利益 | -17.35M | -52.55M | -103.27M | -83.99M | -135.67M | -163.42M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -3.406 | -2.325 | -3.468 | -2.746 | -3.671 | -3.506 |
EBIT | -17.41M | -54.76M | -104.49M | -66M | -130.86M | -161.05M |
EBITDA | -17.41M | -54.6M | -103.99M | -172.82M | -127.98M | -98.33M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約